In order to be eligible for Medicare coverage for hospice services, a healthcare provider must confirm that an individual has a life expectancy of six months or less as a result of their terminal illness.
A patient’s life expectancy can be assessed by meeting specific criteria related to clinical status in Part I.
Furthermore, Part II criteria and disease-specific guidelines can also help determine the required life expectancy.
Part I. Decline in clinical status guidelines
The clinical factors that indicate a likelihood of poor survival are ranked from most predictive to least predictive.
- The progression of the disease, as shown by worsening clinical status, symptoms, signs, and lab results.
- Functional impairment demonstrated by Karnofsky Performance Status (KPS) or Palliative Performance Score (PPS).
- Presence of comorbidities or other medical conditions that may complicate treatment or decrease survival prognosis.
- Inadequate response to previous treatments, indicating potential treatment resistance and disease progression.
Part II. Non-disease specific baseline guidelines
It is essential to meet both non-disease specific and disease-specific guidelines.
- Dependency on assistance for two or more daily activities.
Disease-specific guidelines should be reviewed alongside the baseline guidelines in Part II.
Part III. Co-morbidities
Conditions such as Chronic obstructive pulmonary disease, Congestive heart failure, and others should be taken into account when determining hospice eligibility.
- A list of diseases that could lead to a life expectancy of six months or less.
- It is important to consider co-morbidities, or other medical conditions that a patient may have in addition to their primary terminal illness. These co-morbidities can impact the overall health and prognosis of the patient.
- Examples of common co-morbidities that may affect hospice eligibility include diabetes, kidney disease, and dementia.
- Medical professionals should thoroughly assess and document all co-morbidities when evaluating a patient for hospice care, as they can play a significant role in determining prognosis and eligibility.
Overview/General Guidelines
“>
Disease-Specific Guidelines
“>
Disease Specific Guidelines
Disease-specific guidelines must be considered in conjunction with Part II guidelines.
Section I: Cancer Diagnoses
- Diseases with distant metastases or progression to metastatic disease may qualify for hospice care.
Specific cancers with poor prognoses could also be eligible for hospice without meeting additional criteria.
It is essential for healthcare providers to consider the individual circumstances of each patient when determining eligibility for hospice care. Factors such as overall health, symptoms, and response to treatment should be taken into account when making this decision.
Section II: Non-Cancer Diagnoses
- The progression of ALS varies among patients, requiring the assessment of multiple clinical parameters.
Criteria:
Patients with ALS may be deemed terminal if they meet specific requirements.
- Patients should exhibit severely impaired breathing capacity or rapid ALS progression, or face life-threatening complications.
Patients with dementia, heart disease, or specific disorders should meet certain terminal stage criteria.
Patients eligible for hospice care due to heart disease may have already exhausted optimal treatment options or may not be suitable candidates for surgical interventions. Symptoms like angina at rest or significant heart failure may be present. While not mandatory, other factors such as arrhythmias or a history of cardiac arrest could further support eligibility. Patients with a CD4+ count below 100,000 copies/ml and certain conditions like CNS lymphoma may be considered in the terminal stage. Additionally, patients with decreased performance status, chronic diarrhea, or advanced AIDS dementia may also meet the criteria for hospice care.
For patients with liver disease, eligibility for hospice care may be indicated by criteria such as prolonged prothrombin time or ascites, as well as progressive malnutrition or muscle wasting. Patients with pulmonary disease may qualify based on criteria such as disabling dyspnea and disease progression. Similarly, patients with renal disease may be eligible with acute renal failure and specific comorbid conditions.
Patients who have suffered a stroke or are in a coma may be eligible for hospice care based on factors like a low Karnofsky Performance Status or the inability to maintain hydration. Comatose patients with abnormal brain stem responses or absent verbal responses may also qualify. Documentation of factors such as aspiration pneumonia or sepsis can further support eligibility for hospice care.
End-stage diabetes is a serious condition that typically occurs years after initial diagnosis. Patients with diabetes mellitus may experience elevated blood sugar levels due to insulin deficiency or decreased insulin effectiveness.
In a healthy individual, insulin helps regulate blood sugar levels, maintaining fasting levels below 100 mg/dL and postprandial levels under 140 mg/dL. Glucose serves as the primary energy source for organs like the brain, requiring normal levels for optimal function in the brain, eyes, and retina.
Diabetes encompasses various types, including type I, type II, and gestational diabetes. Type I involves the immune system attacking pancreatic beta cells, while type II is characterized by insulin resistance. The most severe cases are type 1 and type 2 diabetes.
Diabetes progression ranges from insulin resistance to complications associated with type 2 diabetes such as kidney disease, heart failure, and neuropathy. End-stage diabetes can lead to severe complications like kidney issues, heart disease, and nerve damage. Managing blood glucose levels and avoiding high-GI foods are crucial for controlling diabetes.